Management of Iron Deficiency Anemia in Hemodialysis Patients

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 108 participants.

Also called NCT07706582

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07706582
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07706582. Randomized; no masking; primary purpose treatment. Start 2025-11-02 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Management of Iron Deficiency Anemia in Hemodialysis Patients
Condition
Iron Deficiency Anemia (IDA)
Condition
ESRD (End Stage Renal Disease)
Intervention (Dietary supplement)
Lactoferrin
Intervention (Drug)
IV iron sucrose
Lead sponsor
Beni-Suef University (class: other)

Record details

Record id
cardio:ct-nct07706582
Content hash
186717191baa25107a5802e22653e6e81a7bafc8aa57fd839856b8b7d5564070